Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Wuhan YZY Biopharma CoHKSE:02496 Days Inventory is 23.75 as of Dec. 2025, which is 55% below its 10-year median of 52.84. The stock has 8 warning signs investors should review. Among 638 Biotechnology companies, Wuhan YZY Biopharma Co ranks better than 93.26% on this metric.
The historical rank and industry rank for Wuhan YZY Biopharma Co's Days Inventory or its related term are showing as below:
HKSE:02496'
s Days Inventory Range Over the Past 10 Years
Min: 24.07 Med: 52.84 Max: 81.61
Current: 24.07
During the past 5 years, Wuhan YZY Biopharma Co's highest Days Inventory was 81.61. The lowest was 24.07. And the median was 52.84.
HKSE:02496's Days Inventory is ranked better than 93.26% of 638
companies
in the Biotechnology industry
Industry Median: 183.195
vs HKSE:02496: 24.07
Wuhan YZY Biopharma Co's Days Inventory
declined
from Dec. 2024 (38.86) to Dec. 2025 (23.75).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Wuhan YZY Biopharma Co's Inventory Turnover for the
six
months ended in Dec. 2025 was 7.68.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Wuhan YZY Biopharma Co's Inventory-to-Revenue for the
six
months ended in Dec. 2025 was 0.12.
Wuhan YZY Biopharma Co (HKSE:02496) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Wuhan YZY Biopharma Co's Inventory Turnover for the
six
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Wuhan YZY Biopharma Co's Inventory to Revenue for the
six
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Wuhan YZY Biopharma Co Days Inventory Related Terms
Wuhan YZY Biopharma Co Days Inventory Historical Data
* Premium members only.
The historical data trend for Wuhan YZY Biopharma Co's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:02496 vs VRTX, REGN, ALNY: Days Inventory Comparison
For the Biotechnology subindustry, Wuhan YZY Biopharma Co's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Wuhan YZY Biopharma Co Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Wuhan YZY Biopharma Co's Days Inventory distribution charts can be found below:
* The bar in red indicates where Wuhan YZY Biopharma Co's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Wuhan YZY Biopharma Co (HKSE:02496) has a Days Inventory of 23.75 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Wuhan YZY Biopharma Co and its competitors. This is 55% below median its historical median of 52.84. Over the past decade, Wuhan YZY Biopharma Co's Days Inventory has ranged from 24.07 to 81.61. According to the industry distribution chart, Wuhan YZY Biopharma Co ranks #43 out of 638 companies in the Biotechnology industry, placing it in the top 6.7%.
Is Wuhan YZY Biopharma Co's Days Inventory too high?
Wuhan YZY Biopharma Co's current Days Inventory of 23.75 is 55% below median its 10-year median of 52.84. Over the past 10 years, this metric has ranged from a low of 24.07 to a high of 81.61. The Biotechnology industry median Days Inventory is 183.20. Wuhan YZY Biopharma Co's value of 23.75 is 87% below this industry median. Based on the distribution chart, Wuhan YZY Biopharma Co ranks #43 out of 638 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers.
How does Wuhan YZY Biopharma Co's Days Inventory compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Wuhan YZY Biopharma Co ranks #43 out of 638 companies for Days Inventory. This places Wuhan YZY Biopharma Co in the top 7% of its industry — outperforming the majority of peers. The industry median Days Inventory is 183.20. Wuhan YZY Biopharma Co's value of 23.75 is 87% below this benchmark. Historically, Wuhan YZY Biopharma Co's own Days Inventory has ranged from 24.07 to 81.61 over the past decade. While the company's 10-year median is 52.84 vs. the industry median of 183.20, Wuhan YZY Biopharma Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.20, based on 638 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Wuhan YZY Biopharma Co's current Days Inventory of 23.75 is 87% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Wuhan YZY Biopharma Co and its competitors. For the Biotechnology industry, the median Days Inventory is 183.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Wuhan YZY Biopharma Co's current Days Inventory is 23.75, which is 55% below median its own 10-year median of 52.84. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Wuhan YZY Biopharma Co stock overvalued right now?
Wuhan YZY Biopharma Co (HKSE:02496) has a current Days Inventory of 23.75. The current Days Inventory is 23.75, which is 55% below median its 10-year median of 52.84 and 87% below the Biotechnology industry median of 183.20. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Wuhan YZY Biopharma Co (HKSE:02496), the current Days Inventory is 23.75 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Wuhan YZY Biopharma Co Ltd is a biotechnology company dedicated to developing bispecific antibody (BsAb)- based therapies. The Company has been forward-looking in deploying its presence in several therapeutic fields, including but not limited to tumor-associated complications, tumors, ophthalmology, and autoimmune diseases. The Company also proactively established several self-developed technology platforms, such as Y-BODY, Check-Body, and Nano-Ybody, promoting the development of more candidates to clinical stages with high efficiency.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02496 has been successfully added to your 
